2m 2m 2m 2m 2m 2m 2m
ANNEXON (ANNX)
NASDAQ
$5.18+$0.13 (+2.68%)
Price as of Jun 23, 2026 4:40 PM EDT- $825.8MMarket Cap
- 111.76%1-Year Change
- BiotechnologyIndustry
ANNEXON (ANNX)
$5.18+$0.13 (+2.68%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -184.7M +54.63% | -119.4M +5.00% | -113.8M +1.12% | -112.5M +12.43% | |
Depreciation and Amortization Expense | 2.2M +0.74% | 2.1M +0.09% | 2.1M +1.99% | 2.1M -1.63% | |
Total Operating Expenses | 216.4M +40.46% | 154.1M +7.20% | 143.7M -1.29% | 145.6M +11.39% | |
Operating Profit | -216.4M +40.46% | -154.1M +7.20% | -143.7M -1.29% | -145.6M +11.39% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 9.7M -38.78% | 15.9M +67.33% | 9.5M +159.75% | 3.7M +836.41% | |
Income before Taxes | -208.5M +35.36% | -154.1M +7.20% | -143.7M +1.25% | -141.9M +8.92% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -206.7M +49.56% | -138.2M +2.95% | -134.2M -5.43% | -141.9M +8.92% | |
Net Income from Continuing Operations Applicable to Common | -208.5M +50.90% | -138.2M +2.95% | -134.2M -5.43% | -141.9M +8.92% | |
Basic EPS and Net Income | -1.34 +32.67% | -1.01 -42.94% | -1.77 -31.92% | -2.60 -23.53% | |
Diluted EPS and Net Income | -1.34 +32.67% | -1.01 -42.94% | -1.77 -31.92% | -2.60 -23.53% | |
Basic Weighted Average Shares | 155.1M +12.88% | 137.4M +81.58% | 75.7M +38.41% | 54.7M +42.69% | |
Diluted Weighted Average Shares | 155.1M +12.88% | 137.4M +81.58% | 75.7M +38.41% | 54.7M +42.69% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 162.1M +227.39% | 49.5M -78.01% | 225.1M +60.77% | 140.0M +87.08% | |
Short-Term Investments | 76.3M -70.94% | 262.5M +658.59% | 34.6M -66.28% | 102.6M -38.86% | |
Cash and Cash Equivalents and Short-Term Investments | 238.3M -23.61% | 312.0M +20.14% | 259.7M +7.03% | 242.7M -0.02% | |
Total Current Assets | 242.2M -23.47% | 316.5M +19.94% | 263.9M +6.35% | 248.1M +0.16% | |
Accumulated Depreciation | 9.3M +30.17% | 7.2M +42.75% | 5.0M +74.44% | 2.9M +265.40% | |
Property and Plant and Equipment and Net | 10.6M -15.99% | 12.6M -14.45% | 14.8M -12.26% | 16.8M -5.66% | |
Total Long-Term Assets | 8.5M +164.17% | 3.2M -78.10% | 14.8M -12.26% | 16.8M -5.66% | |
Total Assets | 277.6M -20.71% | 350.1M +17.60% | 297.7M +4.41% | 285.1M -0.68% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 42.6M +39.72% | 30.5M +70.19% | 17.9M -19.82% | 22.4M +2.83% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 23.3M -11.95% | 26.5M -9.37% | 29.2M -7.46% | 31.5M -8.40% | |
Total Liabilities | 65.9M +15.72% | 57.0M +20.90% | 47.1M -12.59% | 53.9M -2.23% | |
Retained Earnings | -917.4M +29.08% | -710.7M +24.14% | -572.5M +30.63% | -438.3M +47.90% | |
Total Stockholders Equity | 211.6M -27.79% | 293.1M +16.98% | 250.6M +8.37% | 231.2M -0.31% | |
Total Shares Outstanding | 149.4M +36.55% | 109.4M +39.57% | 78.4M +64.22% | 47.7M +23.76% | |
Cash Flow | |||||
Cash from Operating Activities | -186.4M +57.92% | -118.0M -2.59% | -121.1M +4.16% | -116.3M +9.61% | |
Capital Expenditures | 137,000 +813.33% | 15,000 -92.23% | 193,000 -97.04% | 6.5M +294.56% | |
Cash from Investing Activities | 190.1M +186.86% | -218.8M -409.46% | 70.7M +20.98% | 58.4M +166.23% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 108.9M -32.47% | 161.2M +18.95% | 135.5M +10.26% | 122.9M +6,747.24% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -65.86% +54.35% | -42.67% -7.37% | -46.07% -7.16% | -49.62% +22.41% | |
Return on Equity | -81.90% +61.09% | -50.84% -8.77% | -55.73% -9.09% | -61.30% +35.52% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 5.68 -45.22% | 10.37 -29.53% | 14.72 +32.65% | 11.10 -2.60% | |
Cash Ratio | 3.80 +134.33% | 1.62 -87.08% | 12.56 +100.51% | 6.26 +81.93% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow